+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease (Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories)-Global Forecast to 2025

  • ID: 5028771
  • Report
  • May 2020
  • Region: Global
  • 175 Pages
  • Markets and Markets
1 of 6
The Global Tissue Diagnostics Market is Expected to Reach USD 4.7 Billion by 2025 from USD 3.4 Billion in 2020, at a CAGR of 6.5%.

FEATURED COMPANIES

  • Abbott
  • Amos Scientific Pty Ltd
  • Cell Signaling Technology
  • Dipath S.P.A.
  • Medite Gmbh
  • Sakura Finetek Japan
  • MORE

The global tissue diagnostic market size is projected to register a CAGR of 6.5% during the forecast period.

The growth in this market is driven by the rising incidence of cancer, developing infrastructure for cancer diagnosis, the recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure.

The consumables segment is anticipated to grow at the fastest growth rate during the forecast period.

Based on product type, the tissue diagnostics market is segmented into instruments and consumables. The consumables segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by their requirement in large numbers, cost-effectiveness, and ease of use. The increasing number of reagent rental agreements is also one of the major factors to drive the growth of the consumables market globally.

The immunohistochemistry segment is estimated to grow at a rapid rate during the analysis period.

Based on the technology type, the tissue diagnostic market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to is increasing prevalence of chronic diseases across the globe, where this technology is mostly used in tissue diagnostics.

Asia Pacific is estimated to register the highest CAGR during the study period.

Geographically, the tissue diagnostic market is dominated by North America and followed by Europe in 2019. However, the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. Economic growth in the countries of this region, large population base, rising prevalence of chronic diseases, a rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests, will drive the market in the region over the forecast period.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
  • By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%

The key players in the tissue diagnostic market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), Dipath S.P.A. (Italy).

Research Coverage:

The report analyzes the tissue diagnostic market by product, technology, disease, end-user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any 1, or a combination of the below mentioned 5 strategies to increase their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products of the top players in the tissue diagnostic market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostic market
  • Market Development: Detailed information about emerging markets.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue diagnostic market
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott
  • Amos Scientific Pty Ltd
  • Cell Signaling Technology
  • Dipath S.P.A.
  • Medite Gmbh
  • Sakura Finetek Japan
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Growth Forecast
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Attractive Market Opportunities in the Tissue Diagnostic Market
4.2 Asia Pacific Market: by Disease
4.3 Tissue Diagnostic Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Cancer
5.2.1.2 Growing Healthcare Expenditure
5.2.1.3 Developing Infrastructure for Cancer Diagnosis
5.2.1.4 Recommendations for Cancer Screening
5.2.1.5 Availability of Reimbursements
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation
5.2.3 Opportunities
5.2.3.1 Significant Opportunities in Brics Countries
5.2.3.2 Growing Demand for Personalized Medicines
5.2.3.3 Increasing Number of Clinical Trials Pertaining to Cancer Drugs
5.2.4 Challenges
5.2.4.1 Stringent Regulatory Requirements
5.2.4.2 Lack of Infrastructure and Low Awareness in Middle- and Low- Income Countries
5.2.4.3 Availability of Refurbished Products
5.2.4.4 Lack of Skilled Professionals
5.2.4.5 Product Failures and Recalls
5.2.5 Trends
5.2.5.1 Increasing Number of Reagent Rental Agreements

6 Tissue Diagnostics Market, by Product
6.1 Introduction
6.2 Consumables
6.2.1 Antibodies
6.2.2 Kits
6.2.3 Reagents
6.2.4 Probes
6.3 Instruments
6.3.1 Slide-Staining Systems
6.3.2 Scanners
6.3.3 Tissue-Processing Systems
6.3.4 Other Instruments

7 Tissue Diagnostics Market, by Technology
7.1 Introduction
7.2 Immunohistochemistry (IHC)
7.3 in Situ Hybridization (ISH)
7.4 Digital Pathology and Workflow Management
7.5 Special Staining

8 Tissue Diagnostics Market, by Disease
8.1 Introduction
8.2 Breast Cancer
8.3 Gastric Cancer
8.4 Lymphoma
8.5 Prostate Cancer
8.6 Non-Small Cell Lung Cancer (NSCLC)
8.7 Other Diseases

9 Tissue Diagnostics Market, by End User
9.1 Introduction
9.2 Hospitals
9.3 Research Laboratories
9.4 Pharmaceutical Companies
9.5 Contract Research Organizations
9.6 Other End Users

10 Tissue Diagnostics Market, by Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 Us is Expected to be Dominant Country-Level Market for Tissue Diagnostics
10.2.2 Canada
10.2.2.1 High Prevalence of Cancer in Canada is Expected to Support Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Availability of Reimbursements for Colorectal Cancer Screening
10.3.2 Uk
10.3.2.1 Government Initiatives to Drive the Growth in the Uk
10.3.3 France
10.3.3.1 Increasing Government Funding for Cancer Diagnosis & Prevention to Support the Market Growth
10.3.4 Italy
10.3.4.1 High Incidence of Cancer to Support the Market Growth in Italy
10.3.5 Spain
10.3.5.1 High Incidence of Chronic Diseases to Drive the Spanish Market
10.3.6 Rest of Europe (Roe)
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Increasing Healthcare Expenditure
10.4.2 Japan
10.4.2.1 Advanced Healthcare Infrastructure to Support Market Growth in Japan
10.4.3 India
10.4.3.1 Expanding Healthcare Sector in the Country to Drive Market Growth
10.4.4 Rest of Asia Pacific (Roapac)
10.5 Rest of the World (Row)
10.5.1 Latin America
10.5.1.1 Increasing Number of Cancer Screening Programs to Support Market Growth
10.5.2 Middle East & Africa
10.5.2.1 Increasing Incidence of Cancer in the Middle East & Africa to Support Market Growth

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2019
11.3 Competitive Scenario
11.3.1 Product Launches (2017–2020)
11.3.2 Product Approvals (2017–2020)
11.3.3 Partnerships and Collaborations (2017–2020)
11.3.4 Acquisitions (2017–2020)
11.4 Competitive Leadership Mapping (2018)
11.4.1 Vendor Inclusion Criteria
11.4.2 Visionary Leaders
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, Publisher View)*
12.1 Roche
12.2 Danaher
12.3 Thermo Fisher Scientific
12.4 Abbott
12.5 Agilent Technologies
12.6 Merck Kgaa
12.7 Sakura Finetek Japan
12.8 Abcam
12.9 Becton, Dickinson and Company (Bd)
12.10 Bio Sb
12.11 Biogenex
12.12 Cell Signaling Technology
12.13 Histo-Line Laboratories
12.14 Slee Medical Gmbh
12.15 Amos Scientific Pty Ltd
12.16 Jinhua Yidi Medical Appliance Co.Ltd
12.17 Medite Gmbh
12.18 Cellpath Ltd
12.19 Hologic, Inc.
12.20 Dipath S.P.A.

*Business Overview, Products Offered, Recent Developments, Publisher View Might Not be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Industry Insights
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables

Table 1 Number of Pathologist Per 100,000 Population, by Country, 2018
Table 2 Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 3 Tissue Diagnostics Market for Consumables, by Type, 2018–2025 (USD Million)
Table 4 Tissue Diagnostics Market for Consumables, by Region, 2018–2025 (USD Million)
Table 5 Tissue Diagnostics Market for Antibodies, by Region, 2018–2025 (USD Million)
Table 6 Tissue Diagnostics Market for Kits, by Region, 2018–2025 (USD Million)
Table 7 Tissue Diagnostics Market for Reagents, by Region, 2018–2025 (USD Million)
Table 8 Tissue Diagnostics Market for Probes, by Region, 2018–2025 (USD Million)
Table 9 Tissue Diagnostics Market for Instruments, by Type, 2018–2025 (USD Million)
Table 10 Tissue Diagnostics Market for Instruments, by Region, 2018–2025 (USD Million)
Table 11 Tissue Diagnostics Market for Slide-Staining Systems, by Region, 2018–2025 (USD Million)
Table 12 Tissue Diagnostics Market for Scanners, by Region, 2018–2025 (USD Million)
Table 13 Tissue Diagnostics Market for Tissue-Processing Systems, by Region, 2018–2025 (USD Million)
Table 14 Tissue Diagnostics Market for Other Instruments, by Region, 2018–2025 (USD Million)
Table 15 Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 16 Tissue Diagnostics Market for Immunohistochemistry, by Region, 2018–2025 (USD Million)
Table 17 Tissue Diagnostics Market for in Situ Hybridization, by Region, 2018–2025 (USD Million)
Table 18 Tissue Diagnostics Market for Digital Pathology and Workflow Management, by Region, 2018–2025 (USD Million)
Table 19 Tissue Diagnostics Market for Special Staining, by Region, 2018–2025 (USD Million)
Table 20 Global Cancer Incidence, 2018 Vs.2025
Table 21 Tissue Diagnostics Market, by Disease, 2018–2025 (USD Million)
Table 22 Breast Cancer Incidence, by Region, 2018 Vs. 2025
Table 23 Tissue Diagnostics Market for Breast Cancer, by Region, 2018–2025 (USD Million)
Table 24 Stomach Cancer Incidence, by Region, 2018 Vs. 2025
Table 25 Tissue Diagnostics Market for Gastric Cancer, by Region, 2018–2025 (USD Million)
Table 26 Hodgkin Lymphoma Incidence, by Region, 2018 Vs. 2025
Table 27 Non-Hodgkin Lymphoma Incidence, by Region, 2018 Vs. 2025
Table 28 Tissue Diagnostics Market for Lymphoma, by Region, 2018–2025 (USD Million)
Table 29 Prostate Cancer Incidence, by Region, 2018 Vs. 2025
Table 30 Tissue Diagnostics Market for Prostate Cancer, by Region, 2018–2025 (USD Million)
Table 31 Lung Cancer Incidence, by Region, 2018 Vs. 2025
Table 32 Tissue Diagnostics Market for Non-Small Cell Lung Cancer, by Region, 2018–2025 (USD Million)
Table 33 Tissue Diagnostics Market for Other Diseases, by Region, 2018–2025 (USD Million)
Table 34 Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 35 Tissue Diagnostics Market for Hospitals, by Region, 2018–2025 (USD Million)
Table 36 Tissue Diagnostics Market for Research Laboratories, by Region, 2018–2025 (USD Million)
Table 37 Tissue Diagnostics Market for Pharmaceutical Companies, by Region, 2018–2025 (USD Million)
Table 38 Tissue Diagnostics Market for Contract Research Organizations, by Region, 2018–2025 (USD Million)
Table 39 Tissue Diagnostics Market for Other End Users, by Region, 2018–2025 (USD Million)
Table 40 Tissue Diagnostics Market, by Region, 2018–2025 (USD Million)
Table 41 North America: Tissue Diagnostics Market, by Country, 2018–2025 (USD Million)
Table 42 North America: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 43 North America: Tissue Diagnostics Market for Consumables, by Type, 2018–2025 (USD Million)
Table 44 North America: Tissue Diagnostics Market for Instruments, by Type, 2018–2025 (USD Million)
Table 45 North America: Tissue Diagnostics Market, by Disease, 2018–2025 (USD Million)
Table 46 North America: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 47 North America: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 48 Us Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 49 Us: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 50 Us: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 51 Us: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 52 Canada Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 53 Canada: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 54 Canada: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 55 Canada: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 56 Europe: Tissue Diagnostics Market, by Country, 2018–2025 (USD Million)
Table 57 Europe: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 58 Europe: Tissue Diagnostics Market for Consumables, by Type, 2018–2025 (USD Million)
Table 59 Europe: Tissue Diagnostics Market for Instruments, by Type, 2018–2025 (USD Million)
Table 60 Europe: Tissue Diagnostics Market, by Disease, 2018–2025 (USD Million)
Table 61 Europe: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 62 Europe: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 63 Germany Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 64 Germany: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 65 Germany: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 66 Germany: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 67 Uk: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 68 Uk: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 69 Uk: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 70 France Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 71 France: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 72 France: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 73 France: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 74 Italy Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 75 Italy: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 76 Italy: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 77 Italy: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 78 Spain Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 79 Spain: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 80 Spain: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 81 Spain: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 82 Key Rest of European Countries Lung Cancer Incidence, 2018 Vs. 2025
Table 83 Key Rest of European Countries Liver Cancer Incidence, 2018 Vs. 2025
Table 84 Key Rest of European Countries Breast Cancer Incidence, 2018 Vs. 2025
Table 85 RoE: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 86 RoE: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 87 RoE: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 88 Asia Pacific: Tissue Diagnostics Market, by Country, 2018–2025 (USD Million)
Table 89 Asia Pacific: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 90 Asia Pacific: Tissue Diagnostics Market for Consumables, by Type, 2018–2025 (USD Million)
Table 91 Asia Pacific: Tissue Diagnostics Market for Instruments, by Type, 2018–2025 (USD Million)
Table 92 Asia Pacific: Tissue Diagnostics Market, by Disease, 2018–2025 (USD Million)
Table 93 Asia Pacific: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 94 Asia Pacific: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 95 China Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 96 China: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 97 China: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 98 China: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 99 Japan Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 100 Japan: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 101 Japan: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 102 Japan: Tissue Diagnostics Market, by End User, 2017–2025 (USD Million)
Table 103 India Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 104 India: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 105 India: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 106 India: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 107 Incidence of Cancer in Ropac
Table 108 RoAPAC: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 109 RoAPAC: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 110 RoAPAC: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 111 RoW: Tissue Diagnostics Market, by Region, 2018–2025 (USD Million)
Table 112 RoW: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 113 RoW: Tissue Diagnostics Market for Consumables, by Type, 2018–2025 (USD Million)
Table 114 RoW: Tissue Diagnostics Market for Instruments, by Type, 2018–2025 (USD Million)
Table 115 RoW: Tissue Diagnostics Market, by Disease, 2018–2025 (USD Million)
Table 116 RoW: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 117 RoW: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 118 Key Latin American Countries Lung Cancer Incidence, 2018 Vs. 2025
Table 119 Key Latin American Countries Liver Cancer Incidence, 2018 Vs. 2025
Table 120 Key Latin American Countries Breast Cancer Incidence, 2018 Vs. 2025
Table 121 Latin America: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 122 Latin America: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 123 Latin America: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)
Table 124 Africa Cancer Incidence, by Type of Cancer, 2018 Vs. 2025
Table 125 Middle East & Africa: Tissue Diagnostics Market, by Product, 2018–2025 (USD Million)
Table 126 Middle East & Africa: Tissue Diagnostics Market, by Technology, 2018–2025 (USD Million)
Table 127 Middle East & Africa: Tissue Diagnostics Market, by End User, 2018–2025 (USD Million)

List of Figures

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation from the Parent Market
Figure 5 Data Triangulation Methodology
Figure 6 Tissue Diagnostic Market, by Product, 2020 Vs. 2025 (USD Million)
Figure 7 Tissue Diagnostic Market, by Technology, 2020 Vs. 2025 (USD Million)
Figure 8 Tissue Diagnostic Market, by Disease, 2020 Vs. 2025 (USD Million)
Figure 9 Tissue Diagnostic Market, by End User, 2020 Vs. 2025 (USD Million)
Figure 10 Geographic Snapshot of the Global Tissue Diagnostic Market
Figure 11 Rising Incidence of Cancer to Drive the Growth of the Tissue Diagnostics Market during the Forecast Period
Figure 12 Gastric Cancer Segment Dominated the Apac Market in 2019
Figure 13 China to Register the Highest Growth during the Forecast Period
Figure 14 Tissue Diagnostics Market: Drivers, Restraints, Opportunities, Challenges, and Trends
Figure 15 Current Health Expenditure Per Capita
Figure 16 Current Health Expenditure (% of Gdp)
Figure 17 Growth in Current Healthcare Expenditure Per Capita in Brics Countries, 2012–2016
Figure 18 Number of Articles Related to Tissue Diagnostics Published on Pubmed (2010–2019)
Figure 19 Articles Published on Cancer Tissue Diagnostics, 2010–2019
Figure 20 Articles Published on Breast Cancer Tissue Diagnostics, 2010–2019
Figure 21 Articles Published on Gastric Cancer Tissue Diagnostics, 2010–2019
Figure 22 Articles Published on Lymphoma Tissue Diagnostics, 2010–2018
Figure 23 Articles Published on Prostate Cancer Tissue Diagnostics, 2010–2018
Figure 24 Articles Published on Non-Small Cell Lung Cancer Tissue Diagnostics, 2010–2019
Figure 25 Tissue Diagnostics Market in North America: Snapshot
Figure 26 Tissue Diagnostics Market in Asia Pacific: Snapshot
Figure 27 Product Launches-The most Adopted Growth Strategy from 2017 to 2020
Figure 28 Shares of Top Companies in the Global Tissue Diagnostic Market (2019)
Figure 29 Tissue Diagnostics Market (Global) Competitive Leadership Mapping
Figure 30 Roche: Company Snapshot (2019)
Figure 31 Danaher: Company Snapshot (2019)
Figure 32 Thermo Fisher Scientific: Company Snapshot (2019)
Figure 33 Abbott: Company Snapshot (2019)
Figure 34 Agilent Technologies: Company Snapshot (2019)
Figure 35 Merck: Company Snapshot (2019)
Figure 36 Abcam: Company Snapshot (2019)
Figure 37 Bd: Company Snapshot (2019)
Figure 38 Hologic, Inc: Company Snapshot (2019)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abbott
  • Abcam
  • Agilent Technologies
  • Amos Scientific Pty Ltd
  • Becton, Dickinson and Company (BD)
  • Bio SB
  • Biogenex
  • Cell Signaling Technology
  • Cellpath Ltd
  • Danaher
  • Dipath S.P.A.
  • Histo-Line Laboratories
  • Hologic, Inc.
  • Jinhua Yidi Medical Appliance Co. Ltd
  • Medite Gmbh
  • Merck Kgaa
  • Roche
  • Sakura Finetek Japan
  • Slee Medical Gmbh
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll